Skip to main content
logo
NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
25.59
+0.67 (2.69%)
Sep 2, 2026, 4:00 PM EDT - Market closed

NAMS Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,0593,9782,751920889139
Market Cap Growth
12.93%44.58%199.19%3.44%537.58%-
Enterprise Value
2,3813,2222,329501796-
Last Close Price
25.5935.0825.7011.1710.909.75

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
429.57176.7760.3865.268.66-
PB Ratio
4.775.823.633.192.072.46
P/TBV Ratio
4.855.823.643.192.072.46
P/FCF Ratio
----85.12-
P/OCF Ratio
----83.36-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
334.33143.1851.1235.567.75-
EV/FCF Ratio
----76.18-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
000.00000.00
Debt / FCF Ratio
----0.01-
Net Debt / Equity Ratio
-1.07-1.07-1.10-1.18-1.09-1.06
Net Debt / EBITDA Ratio
2.783.234.731.86131.791.72
Net Debt / FCF Ratio
4.724.925.242.41-44.772.04
Asset Turnover
0.010.030.080.030.38-
Quick Ratio
8.767.698.006.8613.035.81
Current Ratio
9.037.888.076.9513.265.96
Return on Equity (ROE)
-36.81%-28.29%-46.20%-49.25%-9.30%-159.01%
Return on Assets (ROA)
-20.11%-17.27%-18.19%-27.70%-0.81%-55.71%
Return on Capital Employed (ROCE)
-38.70%-33.00%-23.30%-61.60%-0.80%-61.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.48%-5.12%-8.78%-19.24%-2.55%-29.97%
FCF Yield
-4.70%-3.72%-5.79%-15.36%1.18%-21.18%
Buyback Yield / Dilution
-12.87%-25.50%-14.84%-333.20%-72.75%-119.58%
SEC Filings: 10-K · 10-Q